#VisualAbstract: Greater immunosuppression is associated with worse outcomes in patients with advanced melanoma receiving ipilimumab and anti-PD-1 therapy
Click to read the study in the European Journal of Cancer.
Click to read the study in the European Journal of Cancer.
Click to read the study in Nutrients.
Click to read the study in the European Journal of Cancer.
Click to read the study in The Lancet Oncology.
Click to read the study in the European Journal of Cancer.
Click to read the study in the Journal of the American Academy of Dermatology.
Click to read the study in the European Journal of Cancer.
Click to read the study in the Journal of the American Academy of Dermatology.
Click to read the study in The Lancet Oncology. Click to see previously reported survival outcomes from the same cohort.
Click to read the study in The Lancet Oncology.
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.